Replies to post #88887 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

It will be interesting, and ironic, if after Amgen bails the first data readout on NEO shows a significant response to the suboptimal dosing.

[Zoltarak]

Or maybe it's a simple as this:

Their business priorities have changed for FY19 and they are moving in a different direction.